Premium
Clozapine, long‐acting injectables show greatest effectiveness in relapse prevention
Publication year - 2017
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30255
Subject(s) - clozapine , medicine , antipsychotic , schizophrenia (object oriented programming) , cohort , antipsychotic agent , psychiatry , pharmacology
A nationwide cohort study of patients with schizophrenia in Sweden has found significant variability among antipsychotic medications in their effectiveness in preventing rehospitalization. Results in relapse prevention were particularly strong for clozapine and for long‐acting injectable antipsychotics. Study results were published online June 7 in JAMA Psychiatry